QSV Equity Investors’s Astrana Health ASTH Stock Holding History

QSV Equity Investors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$739K	Sell	29,786 -9,672	-25%	-$257K	1.09%	52
2025 Q3	$1.12M	Hold	39,458	–	–	1.14%	48
2025 Q2	$982K	Sell	39,458 -328	-0.8%	-$9.24K	1.02%	54
2025 Q1	$1.23M	Buy	39,786 +10,190	+34%	+$339K	1.28%	42
2024 Q4	$933K	Hold	29,596	–	–	0.9%	58
2024 Q3	$1.71M	Hold	29,596	–	–	1.61%	22
2024 Q2	$1.2M	Sell	29,596 -14	-0%	-$555	1.25%	49
2024 Q1	$1.24M	Buy	+29,610	New	+$1.15M	1.2%	45

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

QSV Equity Investors's ASTH Position: Q4 2025 in Review

QSV Equity Investors reduced its Astrana Health (ASTH) stake by 25% in Q4 2025, selling an estimated $257K and leaving 29,786 shares worth $739K. The position accounts for 1.09% of the portfolio, ranked #52.

QSV Equity Investors first reported a position in ASTH in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.71M in Q3 2024. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

QSV Equity Investors held 29,786 shares of Astrana Health worth $739K as of Q4 2025.
QSV Equity Investors sold 9,672 Astrana Health shares in Q4 2025, an estimated $257K.
Astrana Health made up 1.09% of QSV Equity Investors's portfolio in Q4 2025, its #52 holding.
QSV Equity Investors first reported a position in Astrana Health in Q1 2024 and has held it in 8 quarters since.
QSV Equity Investors's Astrana Health position peaked at $1.71M in Q3 2024.
175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on QSV Equity Investors's 13F filing for Q4 2025, filed 12 Feb 2026.